The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis

Blocking Tumor Necrosis Factor in Ankylosing Spondylitis

NCT00000433 ·Status: COMPLETED ·Phase: PHASE2

Does Etanercept Influence Tweak Modulation of Inflammation During Inflammatory Rheumatisms (Psoriatic Arthritis and Rheumatoid Arthritis)?

NCT02164214 ·Status: COMPLETED ·Phase: PHASE3

Enthesitis Assessment Before and After Anti-Tumor Necrosis Factor Treatment in Spondyloarthritis

NCT04953871 ·Status: COMPLETED ·Phase: PHASE4

Prospective Evaluation of the Radiographic Efficacy of Enbrel

NCT01623752 ·Status: COMPLETED

A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With DMARDs Versus DMARDs Alone in Patients With Rheumatoid Arthritis

NCT01787149 ·Status: UNKNOWN ·Phase: PHASE3

Etanercept (Enbrel) Special Investigation (Regulatory Post Marketing Commitment Plan)

NCT01230177 ·Status: COMPLETED

Efficacy and Safety Study of Tacrobell to Treat Rheumatoid Arthritis

NCT01746680 ·Status: COMPLETED ·Phase: PHASE4

Etanercept to Treat Wegener's Granulomatosis

NCT00001901 ·Status: COMPLETED ·Phase: PHASE2

Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy

NCT00244556 ·Status: COMPLETED ·Phase: PHASE4

Observational Non-Interventional Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis

NCT01188655 ·Status: COMPLETED

Enbrel Liquid Immunogenicity Protocol

NCT00249041 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating Enbrel in Patients With Rheumatoid Arthritis

NCT00245934 ·Status: COMPLETED

Serum Biomarkers Analysis in Patients With AR Treated With Anti-TMF

NCT02804204 ·Status: UNKNOWN

Tc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFα Therapy Response in Moderate to Severe Active RA

NCT05246280 ·Status: TERMINATED ·Phase: PHASE3

Phase 1 Dose Escalation Study of Intra-Articular Administration of tgAAC94

NCT00617032 ·Status: COMPLETED ·Phase: PHASE1

Study Evaluating the Efficacy of Enbrel (Etanercept) in Subjects in Japan

NCT00503503 ·Status: COMPLETED

Effectiveness and Safety of Enbrel® (Etanercept) in Rheumatoid Arthritis Subjects Who Have Failed Remicade® (Infliximab)

NCT00099554 ·Status: COMPLETED ·Phase: PHASE4

Effectiveness of Tele-rheumatology for Delivering High Quality Rheumatology Care During the COVID-19 Crisis (EVOLVE)

NCT04704544 ·Status: COMPLETED ·Phase: NA

Rheumatoid Arthritis DMARD Intervention and UtilizationStudy

NCT00116727 ·Status: COMPLETED

An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.

NCT00891046 ·Status: COMPLETED ·Phase: PHASE3

Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)

NCT02115750 ·Status: COMPLETED ·Phase: PHASE3

Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA)

NCT00886769 ·Status: TERMINATED ·Phase: PHASE3

Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus Methotrexate

NCT01783015 ·Status: TERMINATED ·Phase: PHASE4

Comparison of Two Etanercept Regimens (REUMATOCEPT® Versus ENBREL®) for Treatment of Rheumatoid Arthritis

NCT01394913 ·Status: WITHDRAWN ·Phase: PHASE3

Musculoskeletal Ultrasound in Predicting Early Dose Titration With Tocilizumab

NCT01717859 ·Status: COMPLETED ·Phase: PHASE4